BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Tecaginlimab readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Tecaginlimab\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06057038-2491@assetmemo.bio
DTSTAMP:20261121T005559Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:Tecaginlimab: Phase 1 readout est. (NCT06057038)
DESCRIPTION:Tecaginlimab\, phase 1.\nStudy: A Safety Trial of GEN1042 in Ja
 panese Subjects With Malignant Solid Tumors\nEstimated primary completion:
  August 2027. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/tecagin
 limab#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/N
 CT06057038
URL:https://assetmemo.bio/drug/tecaginlimab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
